These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Petropoulou D; Siopi M; Vourli S; Pournaras S Front Cell Infect Microbiol; 2021; 11():814530. PubMed ID: 35127562 [TBL] [Abstract][Full Text] [Related]
7. Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit. Dudoignon E; Caméléna F; Lafaurie M; Deniau B; Chaussard M; Coutrot M; Guillemet L; Cupaciu A; Pharaboz A; Boutin L; Benyamina M; Chaouat M; Mimoun M; Merimèche M; Mebazaa A; Plaud B; Berçot B; Dépret F; Mellon G Eur J Clin Microbiol Infect Dis; 2024 Jul; 43(7):1453-1459. PubMed ID: 38676856 [TBL] [Abstract][Full Text] [Related]
9. Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug Resistant Velmurugan H; Venkatesan S; Meles HN; Neelambaram K; Thangaraju P Infect Disord Drug Targets; 2024; 24(6):e220124225835. PubMed ID: 38258766 [TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam]. Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435 [TBL] [Abstract][Full Text] [Related]
20. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro]. Zhao C; Xie W; Zhang W; Ye Z; Wu H Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]